IDENTIFICATION AND CHARACTERIZATION OF A NEUTRALIZING MONOCLONAL-ANTIBODY AGAINST BOTULINUM NEUROTOXIN, SEROTYPE-F, FOLLOWING VACCINATION WITH ACTIVE TOXIN
Dr. Brown et al., IDENTIFICATION AND CHARACTERIZATION OF A NEUTRALIZING MONOCLONAL-ANTIBODY AGAINST BOTULINUM NEUROTOXIN, SEROTYPE-F, FOLLOWING VACCINATION WITH ACTIVE TOXIN, Hybridoma, 16(5), 1997, pp. 447-456
Clostridium botulinum may produce any of seven known serotypes of neur
otoxin (BoNT/A-/G), which are the most toxic bacterial proteins known,
Efforts to develop a second-generation vaccine to these toxins would
benefit from the isolation of hybridomas producing neutralizing monocl
onal antibodies (MAbs), We hypothesized that previous efforts to isola
te neutralizing MAbs against various BoNTs failed due to use of toxoid
ed, chemically altered antigens, We employed a novel vaccination regim
en employing native, active, single-chain BoNT/E (scBoNT/E), A number
of the BoNT/E immunized mice were further vaccinated Kith lethal doses
of fully active BoNT/F. MAb 7F8 consistently neutralized BoNT/F in th
ree different assays: in vivo neutralization, passive neutralization,
and neutralization of regional paralysis, There was no detectable reco
gnition and essentially no neutralization of scBoNT/E. The epitope rec
ognized by this MAb was denatured when treated with formalin, urea, gu
anidine chloride, or sodium dodecyl sulfate, Preliminary epitope mappi
ng studies indicate that the MAb bound to a conformational epitope.